Baceca (valproic acid) / Valerio Therap  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Baceca (valproic acid) / Valerio Therap
2005-001474-27: A randomised, double-blinded parallel group study to compare efficacy and tolerability of topically applied Baceca and Tazarotene against placebo and Tazarotene in patients with basal cell carcinoma

Completed
2
50
Europe
Baceca,
TopoTarget A/S
skin cancer of the type of Basal Cell Carcinoma (BCC)
 
 

Download Options